CHI Announces its Screening Summit: Two Program Options at its World Pharma Congress

April 27, 2011 - PRLog -- Cambridge Healthtech Institute (CHI) is pleased to announce its Screening Summit as part of the World Pharma Congress to be held on June 7-9, 2011 at the Sheraton Philadelphia City Center in Philadelphia, PA.

The Screening Summit features two conferences:

June 7-8:  Tools & Technologies for HTS
June 8-9:  Novel Technologies for Cell Based Screening

Those attending will hear the latest in hit triage strategies, applying the newest label free methods, and implementation of stem and primary cells in high throughput screens. Also to be discussed will be the increased utilization of HT-flow cytometry and mass spectroscopy with industry leaders.

The two programs that constitute the Screening Summit, Tools & Technologies for HTS and Evaluating Novel Technologies for Cell Based Screening, are full of new technologies and new uses for existing technologies, such as:

The Challenges of Using Primary Cells in Drug Discovery
Marcie Glicksman, Ph.D., Co-Director, Laboratory for Drug Discovery, Harvard NeuroDiscovery Center, Partners Center for Drug Discovery; Assistant Professor, Neurology, Brigham and Women’s Hospital

High Dimensional Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across Healthy Human Hematopoiesis and Related Malignancies
Garry P. Nolan, Ph.D., Professor, Microbiology and Immunology, Baxter Laboratory for Stem

Cell Biology, Center for Clinical Science Research, Stanford University
Changing the Game in Ion Channels: Ultra High-Throughput Automated Electrophysiology

Adam Hendricson, Ph.D., Applied Biotechnology & Lead Evaluation, Bristol-Myers Squibb
Combining Label Free Assay Platforms to Support both Large and Small Molecule Drug Discovery

Robin Barbour, Director, Antibody Technology, Neotope Biosciences, a Division of Elan Pharmaceuticals, Inc.

Translating Technologies Outside the HTS Lab
Litao Zhang, Ph.D., Executive Director, Applied Biotechnology, Lead Evaluation and

Mechanistic Biochemistry, Bristol-Myers Squibb

View full details and register at: http://www.WorldPharmaCongress.com

Those that register by April 29 will receive the advanced registration discount.

Writers and editors are invited to attend.  To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (http://www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
http://www.WorldPharmaCongress.com